Quantum Genomics Société Anonyme (ALQGC.PA)

EUR 0.07

(0.0%)

Operating Expenses Summary of Quantum Genomics Société Anonyme

  • Quantum Genomics Société Anonyme's latest annual operating expenses in 2023 was 1.71 Million EUR , up 257.94% from previous year.
  • Quantum Genomics Société Anonyme's latest quarterly operating expenses in 2024 Q2 was 1.12 Million EUR , down 0.0% from previous quarter.
  • Quantum Genomics Société Anonyme reported a annual operating expenses of 479.95 Thousand EUR in annual operating expenses 2022, down -83.49% from previous year.
  • Quantum Genomics Société Anonyme reported a annual operating expenses of 2.9 Million EUR in annual operating expenses 2021, up 50.86% from previous year.
  • Quantum Genomics Société Anonyme reported a quarterly operating expenses of 606.34 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • Quantum Genomics Société Anonyme reported a quarterly operating expenses of 137.19 Thousand EUR for 2023 FY, down -71.42% from previous quarter.

Annual Operating Expenses Chart of Quantum Genomics Société Anonyme (2023 - 2012)

Historical Annual Operating Expenses of Quantum Genomics Société Anonyme (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 1.71 Million EUR 257.94%
2022 479.95 Thousand EUR -83.49%
2021 2.9 Million EUR 50.86%
2020 1.92 Million EUR -82.07%
2019 10.74 Million EUR -20.85%
2018 13.57 Million EUR 32.27%
2017 10.26 Million EUR 338.35%
2016 2.34 Million EUR 40.81%
2015 1.66 Million EUR 9.22%
2014 1.52 Million EUR 82.97%
2013 832.28 Thousand EUR 567.29%
2012 124.72 Thousand EUR 0.0%

Peer Operating Expenses Comparison of Quantum Genomics Société Anonyme

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR 58.871%
ABIVAX Société Anonyme 127.37 Million EUR 98.651%
Adocia SA 15.62 Million EUR 89.008%
Aelis Farma SA 18.81 Million EUR 90.871%
Biophytis S.A. 14.33 Million EUR 88.014%
Advicenne S.A. 8.21 Million EUR 79.087%
genOway Société anonyme 16.73 Million EUR 89.736%
IntegraGen SA 5.35 Million EUR 67.904%
Medesis Pharma S.A. 1.56 Million EUR -9.804%
Neovacs S.A. 10.34 Million EUR 83.391%
NFL Biosciences SA 4.37 Million EUR 60.726%
Plant Advanced Technologies SA 2.76 Million EUR 37.864%
Sensorion SA 27.05 Million EUR 93.65%
Theranexus Société Anonyme 3 Million EUR 42.83%
TME Pharma N.V. 5.49 Million EUR 68.747%
Valbiotis SA 9.86 Million EUR 82.592%
TheraVet SA 1.64 Million EUR -4.479%
Valerio Therapeutics Société anonyme 20.32 Million EUR 91.545%
DBV Technologies S.A. 89.4 Million EUR 98.078%
Genfit S.A. 54.8 Million EUR 96.865%
GeNeuro SA 14.35 Million EUR 88.034%
Innate Pharma S.A. 64.57 Million EUR 97.339%
Inventiva S.A. 120.18 Million EUR 98.571%
MaaT Pharma SA 21.59 Million EUR 92.046%
MedinCell S.A. 32.92 Million EUR 94.782%
Nanobiotix S.A. 58.92 Million EUR 97.085%
OSE Immunotherapeutics SA 23.58 Million EUR 92.717%
Poxel S.A. 28.76 Million EUR 94.028%
GenSight Biologics S.A. 32.66 Million EUR 94.74%
Transgene SA 31.23 Million EUR 94.499%
Valneva SE 134.92 Million EUR 98.727%